ORIGINAL RESEARCH article

Front. Vet. Sci., 25 August 2020

Sec. Veterinary Epidemiology and Economics

Volume 7 - 2020 | https://doi.org/10.3389/fvets.2020.00503

Genome Characterization of mcr-1–Positive Escherichia coli Isolated From Pigs With Postweaning Diarrhea in China

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, China Agricultural University, Beijing, China

Abstract

Diarrheagenic Escherichia coli is the causative agent of diarrhea in infants and animals worldwide. Many isolated strains recovered from pigs with postweaning diarrhea are multidrug resistance (MDR), and hybrids of E. coli are potentially more virulent, as enterotoxigenic E. coli (ETEC)/Shiga-toxigenic E. coli (STEC) hybrids. Here, we used whole-genome sequencing to analyze clinical isolates of the five colistin-resistant E. coli. The E. coli CAU15104, CAU15134, and CAU16060 belonged to ETEC/STEC hybrids, displaying the same serotype O3:H45 and sequence type ST4214. The E. coli CAU16175 and CAU16177 belonged to atypical enteropathogenic E. coli (aEPEC), display O4:H11 and O103:H2, ST29, and ST20, respectively. The E. coli CAU16175 carries six plasmids. An IncHI2-type plasmid, pCAU16175_1, harbors an IS26-enriched MDR region, which includes 16 antimicrobial-resistant genes. An IncFII-type plasmid, pCAU16175_3, harbors mcr-1.1, tet(M), and blaTEM−1B, whereas mcr-1.1 is located within a Tn2 derivative. Our findings indicate that the ETEC/STEC strains of the O3:H45 serotype as well as the aEPEC strains of the O4:H11 and O103:H2 serotypes are associated with postweaning diarrhea in swine and that some of diarrheagenic E. coli contains IS26-enriched MDR region and the mcr-1 gene located within a Tn2 derivative on IncFII plasmid.

Introduction

Diarrheagenic Escherichia coli (DEC) is a leading cause of infectious diarrhea in humans and animals around the world (, ). Diarrheagenic E. coli has six well-described pathotypes: enteropathogenic E. coli (EPEC), which is subdivided into typical EPEC (tEPEC) and atypical EPEC (aEPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli, enteroaggregative E. coli, diffusely adherent E. coli, and enterohemorrhagic E. coli, which is subgroup of Shiga-toxigenic E. coli (STEC) (, ). All of these DECs possess diverse virulence factors, which are encoded by virulence genes and are responsible for their pathogenicity (). Enterotoxigenic E. coli strains typically produce one or two toxins, heat-labile enterotoxin (LT) encoded by ltc, and heat-stable enterotoxin (ST) encoded by st (). In pigs, STEC strains are characterized by producing the Shiga-like toxin variant Stx2e encoded by stx2e (). Enteropathogenic E. coli strains are defined as forming the attaching and effacing (A/E) lesions mediated by genes located on the locus of enterocyte effacement (LEE) pathogenicity island (including eae) in the intestinal epithelium but not produce Shiga-like toxin (Stx) (). Moreover, bfpA, which encodes the major subunit of bundle forming pili, is used to subdivide EPEC into tEPEC and aEPEC. Hence, aEPEC strains are defined by eae+, bfpA, and stx (). Three pathotypes (ETEC, STEC, EPEC) are major DEC causing postweaning diarrhea (PWD) in pigs, and many hybrids of E. coli (ETEC/STEC, ETEC/STEC/EPEC) are present during PWD (, ). The recent data from The Global Enteric Multicenter Study showed that tEPEC and ETEC associated with a higher risk of fatal outcomes in children younger than 24 months with moderate to severe diarrhea (). Atypical EPEC has outbreaks linked to diarrhea in children ().

The occurrence of antimicrobial resistance and prevalence of multidrug resistance (MDR) Gram-negative Enterobacteriaceae has been increasing worldwide between humans and animals (). In the cases of PWD, antimicrobial treatment has been widely used and caused severe drug resistance in DEC (, , ). In our previous study, among the 171 E. coli isolates, 94.15% of the strains were MDR, with antimicrobial resistance rates ranging from 2.34% for meropenem to 90.05% for nalidixic acid (). Among the ETEC strains that cause PWD, resistance to apramycin, neomycin, trimethoprim sulfonamide, and colistin has been increasingly observed (). Multidrug resistance strains may spread from animals to humans, causing antibiotics ineffective and increasing mortality and morbidity in developing countries ().

Colistin as the last resort treatment against MDR bacterial infections may have been challenged by the mobile colistin-resistant gene (mcr-1), which has received widespread attention in different species of Enterobacteriaceae found in animals and humans around the world since it was first reported (). So far, nine allelic variants of mcr-1 (mcr-2 to mcr-10) have been detected (, ). In addition, they have large number of variants, such as mcr-1 (mcr-1.1 to mcr-1.22), mcr-2 (mcr-2.1 to mcr-2.3), mcr-3 (mcr-3.1 to mcr-3.30), mcr-4 (mcr-4.1 to mcr-4.6), mcr-5 (mcr-5.1 to mcr-5.4), and mcr-8 (mcr-8.1 and mcr-8.2) (). Our previous study found that the resistance rate to colistin was 20.47% in 171 E. coli isolates (), and a recent article reported that direct sample testing rates of mcr-1 were higher than the rates of mcr-1–positive E. coli (64.6 vs. 49.2%) ().

Insertion sequences (ISs) and transposons (Tns), arguably most numerous autonomous transposable elements, are crucial to shape their host genomes, particularly important in the bacterial antimicrobial resistance (). IS26 and Tn2, which is a member of the IS6 family and Tn3 family, respectively, play a key role in the dissemination of antimicrobial-resistant genes in Gram-negative bacteria (, ). IS26 is often existed in MDR Gram-negative bacteria, which usually carry large regions containing several antimicrobial-resistant genes that are flanked by and interspersed with copies of IS26 (). Tn2 is the most abundant in commensal E. coli. (). ISSwi1-m2 in pNJST258C2 is a derivative of Tn2 that includes IS26 compared with Tn2 (). ISApl1, which is an IS initially identified in Actinobacillus pleuropneumoniae, is a member of the IS30 family and is considered to be an essential element in the mobilization of mcr-1 (, ).

In the present study, we used whole-genome sequencing (WGS) to analyze virulence and resistant genes of the five clinical colistin-resistant E. coli isolates recovered from pigs with PWD and to characterize the complete sequence of a Tn2 derivative carrying mcr-1.1 on IncFII plasmid, pCAU16175_3, from a swine aEPEC isolate.

Materials and Methods

Bacterial Isolation and Identification

A total of 455 E. coli strains were obtained from feces samples or small intestinal content from pigs with diarrhea in China between 2014 and 2016 and identified with polymerase chain reaction (PCR) amplification of the uspA gene (). Of these, 171 E. coli isolates were further screened by antimicrobial susceptibility testing, and the resistance rate of colistin was 20.47% (). From these 35 colistin-resistant E. coli, we observed ST4214 was a major clone (6/35, 17.14%) based on the multilocus sequence typing and caused severe damage to IPEC-J2 cells (). Then, ST4214 E. coli CAU15014, CAU15134, and CAU16060 were selected from different swine farms (one isolate per farm), and two MDR aEPEC isolates (E. coli CAU16175 and CAU16177) were randomly chosen for WGS.

Antimicrobial Susceptibility Testing

The susceptibility of the five isolates to 18 antimicrobials were tested by determining the minimum inhibitory concentration (MIC) using the US Clinical and Laboratory Standards Institute (CLSI) broth micro method (). The results of MIC for ampicillin (AMP), co-amoxiclav (AMC), cefazolin (CZ), kanamycin (KAN), gentamicin (GEN), amikacin (AMK), tetracycline (TE), trimethoprim-sulfamethoxazole (SXT), ciprofloxacin (CIP), nalidixic acid (NAL), chloramphenicol (CHL), and nitrofurantoin (NIT) were interpreted according to guidelines of CLSI 2016 M100-S26 (). The results of MIC for ceftiofur (EFT), enrofloxacin (ENR), and florfenicol (FFC) were interpreted according to CLSI VET01-A4 (). In addition, the results with MIC values were defined resistant: streptomycin (STR) ≥64 μg/mL (), olaquindox (OLA) ≥64 μg/mL (), and polymyxin B (PB) >2 μg/mL (). Escherichia coli ATCC 25922 was used as the quality control. According to the MIC determined for each antimicrobial, the isolates were defined as “susceptible,” “intermediate,” or “resistant.”

Whole-Genome Sequencing

Bacterial isolates were recultured from stock; DNA was extracted using a TIANamp Bacteria DNA kit (Tiangen Biotech Inc., Beijing, China). We used WGS by the Illumina Hiseq platform to get draft genome of the five E. coli isolates and further used WGS by the Oxford Nanopore Technologies MinION platform to get complete genome of the E. coli CAU16175.

The complete genome assembly was constructed from the two sequence data sets using Unicycler (Shanghai Majorbio Bio-pharm Technology Co., Ltd., Shanghai, China). The serotype, multilocus sequence type, plasmid type, antimicrobial-resistant gene, and virulence gene detection were performed using the Center for Genomic Epidemiology server (https://cge.cbs.dtu.dk). Insertion sequence typing was carried out using the ISFinder database (https://www-is.biotoul.fr/). The complete genome sequences were initially annotated with Rapid Annotation using the Subsystem Technology server (http://rast.nmpdr.org) and curated manually using the BLAST server (https://blast.ncbi.nlm.nih.gov/Blast). The obtained plasmid sequences were aligned with homologous plasmid sequences from NCBI using the BRIG tool ().

Conjugation Assay

The conjugation experiment was carried out using the E. coli CAU16175 as the donor and the E. coli J53 (resistant to sodium azide) as the recipient. The transconjugant was screened on BHI agar plates containing sodium azide (150 mg/L) and colistin (4 mg/L). The presence of mcr-1 in the transconjugant was confirmed by PCR, and the MICs of antimicrobial agents for the transconjugant were determined using the agar dilution method. The conjugation experiment was repeated three times, and the conjugation frequencies were calculated as the number of transconjugants per recipient. The transconjugant strains were distinguished from donor occurring natural mutants of sodium azide–resistant E. coli by verifying eae, which is marker gene for E. coli CAU16175 donor.

GenBank Accession Number

The draft genome sequences of the E. coliCAU15104, CAU15134, CAU16060, and CAU16177 isolates have been deposited at GenBank under SRA accession no. SRR10828049, SRR10828048, SRR10828047, and SRR10828046, respectively. The complete genome sequences of the E. coli CAU16175 have been deposited at GenBank under SRA accession no. SRR10813965.

Results

Antimicrobial Susceptibility Testing of the Five E. coli Isolates

Antimicrobial susceptibility testing of the five isolates showed that they were MDR exhibiting resistant to at least three different classes of antimicrobials (Table 1). All the isolates showed MDR to KAN, STR, TE, SXT, NAL, and PB.

Table 1

StrainAntibiotics
AMPAMCEFTCZKANGENSTRAMKTESXTCIPENRNALCHLFFCNITOLAPB
CAU15104SRRRRSRIRRRRRRSSIR
CAU15134RSSSRSRSRRSSRSIISR
CAU16060RRISRSRSRRIRRRSRIR
CAU16175RRRRRRRSRRRRRRRSIR
CAU16177SRRSRRRSRRSIRRSRIR

Antimicrobial susceptibility profile of the five E. coli isolates.

AMP, ampicillin; AMC, co-amoxiclav; EFT, ceftiofur; CZ, cefazolin; KAN, kanamycin; GEN, gentamicin; STR, streptomycin; AMK, amikacin; TE, tetracycline; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin; ENR, enrofloxacin; NAL, nalidixic acid; CHL, chloramphenicol; FFC, florfenicol; NIT, nitrofurantoin; OLA, olaquindox; PB, polymyxin B.

Characterization of the E. coli Isolates From the Draft Genome Sequences

The clinical isolates of the E. coli CAU15104, CAU15134, and CAU16060 belonged to ETEC/STEC (ltcA+, stb+, and stx+) hybrid strains, display the same serotype O3:H45 and sequence type ST4214, which are identical sequence type with the strains swine19 (LVMV00000000), swine22 (LVMY00000000), swine54 (LVMV00000000), and swine67 (LVOR00000000) from the NCBI database, all carrying fedA, fedF, iha, stb, ltcA, sepA, stx2A, and stx2B virulence genes and antimicrobial-resistant genes conferring resistant to KAN (aph(3)-Ia), STR (aadA2, strA, and strB), TE [tet(A) and tet(M)], SXT (dfrA12, sul1, sul2, and sul3) and PB (mcr-1.1) (Tables 1, 2). Besides, the E. coli CAU15104, CAU15134, and CAU16060 carry cmlA1 and floR, which are associated to phenicol antibiotic (Table 2). The E. coli CAU15104 and CAU15134 carry qnrS2 (associated to quinolone antibiotic) and aac(6)Ib-cr (associated to quinolone and aminoglycoside antibiotic). The E. coli CAU15134 and CAU16060 carry dfrA1 (associated to SXT), mcr-3.1 (associated to PB), oqxA, and oqxB, which are efflux pump conferring antibiotic resistance, and exhibit resistant to AMP associated to blaTEM−1B.

Table 2

StrainCollection dateCollection provinceSerotypeMLSTPlasmid typeAntimicrobial resistance geneVirulence geneGenBank accession no.
CAU151042015ShandongO3:H45ST4214IncF, IncI1aac(6′)Ib-cr, aadA1, aadA2, aph(3′)-Ia, blaCMY−2, cmlA1, dfrA12, erm(B), floR, mcr-1.1, mph(A), qnrS2, strA, strB, sul1, sul2, sul3, tet(A), tet(M)fedA, fedF, iha, ltcA, sepA, stb, stx2A, stx2BWVUR00000000
CAU151342015LiaoningO3:H45ST4214IncF, IncI1, IncHI2aac(6′)Ib-cr, aadA2, aph(3′)-Ia, blaTEM−1B, cmlA1, dfrA1, dfrA12, floR, mcr-1.1, mcr-3.1, oqxA, oqxB, qnrS2, strA, strB, sul1, sul2, sul3, tet(A), tet(M)astA, fedA, fedF, gad, iha, ltcA, sepA, sta1, stb, stx2A, stx2BWVUQ00000000
CAU160602016ShandongO3:H45ST4214IncF, IncHI2aadA2, aph(3′)-Ia, blaTEM−1B, cmlA1, dfrA1, dfrA12, floR, mcr-1.1, mcr-3.1, oqxA, oqxB, strA, strB, sul1, sul2, sul3, tet(A), tet(M)fedA, fedF, gad, iha, ltcA, sepA, sta1, stb, stx2A, stx2BWVUP00000000
CAU161752016HunanO4:H11ST29IncHI2, IncFIB, IncFIIaac(3)-IVa, aac(6′)Ib-cr, aadA1, aadA2, aph(3′)-Ia, aph(4)-Ia, ARR-3, blaOXA−1, blaTEM−1B, catB3, cmlA1, dfrA12, floR, mcr-1.1, sul1, sul2, sul3, tet(A), tet(M)astA, cif, eae, efa1, espA, espB, espJ, gad, iha, iss, katP, lpfA, nleB, nleC, perA, toxB, tirCP047378-CP047384
CAU161772016HunanO103:H2ST20IncF, IncHI2aac(3)-IVa, aac(6′)Ib-cr, aph(3′)-Ia, aph(4)-Ia, ARR-3, blaOXA−1, blaOXA−10, catB3, cmlA1, dfrA12, dfrA14, floR, mcr-1.1, mcr-3.1, oqxA, oqxB, qnrS1, strA, strB, sul1, sul2, sul3, tet(A)cif, eae, espA, espB, espF, espJ, gad, iss, nleA, nleB, tirWVUO00000000
swine192014JiangsuO130:H45ST4214IncA/CaadA2, strA, strB, mcr-1.1, sul3, sul1, tet(A), cmlA1, blaTEM−1B, oqxB, oqxAastA, fedA, fedF, iha, sta1, stb, stx2A, stx2BLVMV00000000
swine222014JiangsuO130:H45ST4214IncA/CaadA2, strA, strB, mcr-1.1, sul3, sul1, tet(A), cmlA1, blaTEM−1B, oqxB, oqxAastA, fedA, fedF, iha, sta1, stb, stx2A, stx2BLVMY00000000
swine542012JiangsuO3:H45ST4214IncA/Caph(3')-Ia, strA, strB, aadA2, mcr-1.1, sul3, sul2, sul1, dfrA12, tet(A), tet(M), cmlA1, floR, blaTEM−1B, oqxA, oqxBastA, fedA, fedF, gad, ltcA, iha, sepA, sta1, stb, stx2A, stx2BLVOE00000000
swine672012JiangsuO3:H45ST4214IncA/CaadA2, aph(3')-Ia, strA, strB, sul3, sul2, sul1, oqxB, oqxA, qnrS2, dfrA12, tet(A), tet(M), mcr-1.1, cmlA1, floR, blaTEM−1B, aac(6')Ib-crastA, fedA, fedF, ltcA, iha, stb, sepA, stx2A, stx2BLVOR00000000

Overview of the molecular typing, antimicrobial resistance genes and virulence genes of the five E. coli isolates from the whole-genome sequencing result by the Illumina Hiseq platform (CAU16175 Illumina/Nanopore) and four ST4214 E. coli strains from the NCBI database.

The clinical isolates of the E. coli CAU16175 and CAU16177, belonged to aEPEC (eae+, bfpA, and stx), display different serotype and sequence type, O4:H11 and O103:H2, ST29 and ST20, respectively. They both carry cif, eae, espA, espB, espJ, gad, iss, nleB, and tir virulence genes and antimicrobial-resistant genes conferring resistance to beta-lactam antibiotic (blaOXA−1), KAN (aph(3)-Ia), GEN (aac(3)-IVa), STR (aadA1 or aadA2 or strA or strB), TE [tet(A) and/or tet(M)], SXT (dfrA12, sul1, sul2, sul3, and/or dfrA14), and PB (mcr-1.1 and/or mcr-3.1) (Tables 1, 2). In addition, the E. coli CAU16175 and CAU16177 both carry aac(6)Ib-cr (associated to quinolone and aminoglycoside antibiotic), aph(4)-Ia (associated to aminoglycoside antibiotic), ARR-3 (associated to rifamycin antibiotic), catB3, cmlA1, and floR (associated to phenicol antibiotic) (Table 2). Interestingly, we observed that the mcr-1.1 gene and the blaTEM−1B gene existed in the same scaffold of the E. coli CAU16175 draft genome. Besides, partial sequences of this scaffold including mcr-1.1 and blaTEM−1B are highly homologous with Tn2 (KT002541).

Complete Genome of the E. coli CAU16175

The 6.07-Mb complete genome of E. coli CAU16175 has a total GC content of 50.47% with a single chromosome and six plasmids. The 5.62 Mb chromosome has a GC content of 50.66%. The six plasmids sequences of E. coli CAU16175 range in length from 6.99 to 190.22 kb with a GC content from 47.10 to 51.35% (Table 3). The chromosome harbors LEE T3SS effectors, non-LEE T3SS effectors, and mdf (A) antimicrobial-resistant gene. The pCAU16175_1 (IncHI2 type) harbors an IS26-enriched MDR region, which includes blaOXA−1 and 15 additional antimicrobial-resistant genes. The pCAU16175_2 (IncFIB type) harbors katP, sepA, and perA virulence genes. The pCAU16175_3 (IncFII type) harbors mcr-1.1, tet(M), and blaTEM−1B antimicrobial-resistant genes. The pCAU16175_5 harbors celb virulence gene (Table 3).

Table 3

Sequence length (bp)GC%Plasmid rep type(s)Antimicrobial resistance geneVirulence region or geneGenBank accession no.
Chromosome561538950.66NAmdf(A)LEE, non-LEE T3SS effectorsCP047378
pCAU16175_119021947.10IncHI2aac(6')-Ib-cr, sul1, sul2, sul3, blaOXA−1, tet(A), ARR-3, aac(3)-IVa, aadA1, aadA2b, aph(3')-Ia, aph(4)-Ia, catB3, cmlA1, floR, dfrA12CP047379
pCAU16175_216117647.91IncFIB (AP001918)katP, sepA, perACP047380
pCAU16175_37663351.35IncFII (29)tet(M), mcr-1.1, blaTEM−1BCP047381
pCAU16175_41067549.23CP047382
pCAU16175_5709850.52celbCP047383
pCAU16175_6698847.58CP047384

Genome summary for ST29 aEPEC isolate CAU16175.

Conjugation Assay

The susceptibility testing of polymyxin B and E showed that the MIC values for the transconjugants (J53-mcr-1) increased to 8 and 16 mg/L, respectively (Table 4). The conjugation frequency was 2.1 × 10−8 transconjugants per recipient.

Table 4

CAU16175J53J53-mcr-1
TE3211
GEN>320.50.5
AMK16162
KAN>12882
AMP>6444
CFZ>1611
CIP>16<0.125<0.125
CHL3212
RFP<1<1<1
PB418
PE16216
STR>256322
NaN3<75300300
EFT16<1<1
FFC3284
AMC>1644

Minimum inhibitory concentration (mg/L) for CAU16175, J53, and J53-mcr-1.

TE, tetracycline; GEN, gentamicin; AMK, amikacin; KAN, kanamycin; AMP, ampicillin; CFZ, cefazolin; CIP, ciprofloxacin; CHL, chloramphenicol; RFP, rifapentine; PB, polymyxin B; PE, polymyxin E; STR, streptomycin; EFT, ceftiofur; FFC, florfenicol; AMC, co-amoxiclav. Highlight the colistin resistance was transferred to J53.

Genetic Characterization of the pCAU16175_1 Harboring the MDR Region

The 190.22-kb plasmid pCAU16175_1 was blasted against the GenBank nucleotide collection (nr/nt) database. An overall nucleotide sequence identity (99.66–99.86%) with query coverages of 90–99% to pSH16G4498 (MH522423), pSH16G2457 (MH522421), pHNYJC8 (KY019259), pHNLDF400 (KY019258), pHXY0908 (KM877269), and other 25 IncHI2-type plasmids were observed (Supplementary Table 1). We chose the five most similar plasmids for comparison analysis; these plasmids have MDR regions and many IS6 family insert sequences (IS26/IS15DI/IS15DIV/IS1006/ISEc59) (Figure 1). The pCAU16175_1 shows almost exactly the same sequence in MDR region with pSH16G4498 and pSH16G2457, which both existed in Salmonella typhimurium recovered from humans in China (Supplementary Table 1). In the pCAU16175_1, the MDR region locates at nucleotide location 121,521–178,916 (56,625 bp). The structure of the MDR region comprises twelve IS6 family insert sequence [including six copies IS26, three copies IS15DI (3 bp differ with IS26), one copy IS15DIV (1 bp differ with IS26), one copy IS1006, and one copy ISEc59] that flank containing different antimicrobial-resistant genes. The MDR region contains floR, sul2, aph(4)-Ia, aac(3)-IVa, aac(6')-Ib-cr, blaOXA−1, catB3, ARR-3, sul1 (two copies), dfrA12, aph(3')-Ia, sul3, aadA1, cmlA1, aadA2b, and tet(A). The MDR region is also interspersed with a number of different mobile elements including ΔTnAs3, ΔISVsa3, ISVsa3, ISAba1, ΔTn5393, ΔTn2, ΔIS15, and ΔTnAs1.

Figure 1

Genetic Characterization of the pCAU16175_3 Harboring the mcr-1.1 Gene

The 76.63-kb plasmid pCAU16175_3 was blasted against the GenBank Nucleotide collection (nr/nt) database. An overall nucleotide sequence identity (94.46–97.88%) with query coverages of 80–89% to pEC1515-3 (CP021847), pEC974-3 (CP021843), pH1038-142 (KJ484634), pFORC_081_1 (CP029058), plasmid R1 (KY749247), and other 27 IncFII-type plasmids were observed (Supplementary Table 2). We chose five most similar IncFII-type plasmids and reported IncFII-type plasmid-mcr-1pKP81-BE (KU994859) for comparison analysis (Figure 2). Although the pCAU16175_3 demonstrates highly sequence homology with the other five IncFII-type plasmids, the mcr-1.1 gene only exists in pCAU16175_3 and pKP81-BE. Besides the mcr-1.1 gene, the pCAU16175_3 also carries the antimicrobial-resistant gene blaTEM−1B and tet(M), which are close to the mcr-1.1 gene.

Figure 2

Noticeably, the nucleotide location of the pCAU16175_3 from 2,079 to 12,231 has high homology with the Tn2 derivative (Figure 3A). This structure is a unique identification compared with the NCBI database and was confirmed by conventional PCR (Supplementary Figure 1A). The genetic content of the structure analysis showed that the structure is located within mcmM (encoded microcin M). A five-nucleotide direct duplication (TATTT) was identified flanking the structure. Unlike the Tn2, this structure harbors mcr-1pap2-ΔISApl1 and IS1X2-hp-tet(M)-IS15DI, deletes the resolvase (tnpR), and truncates the transposase (tnpA). Besides, the striking features of the insertion sites of ISApl1 were found, which includes high AT content and 2-bp direct repeats (DRs) (AA) (Figure 3B). From the result of conjugation experiment and PCR, the whole structure gene did not occur transposition (Table 4, Supplementary Figure 1B). The mcr-1 gene was transferred to J53 without the pap2 gene, whereas colistin resistance was transferred to J53. IS15DI was also transferred to J53.

Figure 3

). Shown sequences represent 10 base pairs upstream and downstream of insertion site, and 2-base-pair direct repeats in brackets. Numbers represent positions in the indicated sequences deposited in GenBank.

Discussion

Postweaning diarrhea caused by DEC is an economically important disease for the swine industry around the world. In our previous study, we collected 455 E. coli isolates recovered from feces samples or small intestinal content from pigs with diarrhea in China between 2014 and 2016 to know the E. coli pathotype and the antimicrobial susceptibility of the isolates (). Most of the isolates belonged to ETEC, followed by aEPEC, which is similar to the report in Spain; that is, most cases of PWD are significantly associated with ETEC (67%) and aEPEC (21.7%) (). Our previous study showed that 95.91% of 171 E. coli isolates were MDR exhibiting resistance to at least three different classes of antimicrobials, and 20.47% E. coli isolates were resistant to colistin. It has been revealed that MDR isolates that existed in swine industry are associated with the widespread use of antibiotics (, ). Overuse of colistin is considered to contribute to the emergence and spread of mcr-1 (). The 36 mcr-1–positive E. coli isolates recovered from pigs with PWD showed MDR (). In this study, we used WGS to analyze the five MDR (including colistin resistance) of E. coli isolates from pigs with PWD and found that they demonstrate different serotype and sequence type and carry different antimicrobial-resistant genes and virulence genes.

The clinical isolates of the E. coli CAU15104, CAU15134, and CAU16060 belonged to ETEC/STEC, displaying the same serotype O3:H45 and sequence type ST4214. As far as we know, there are no reports about this clone strains, and only four have WGS of these clone strains. The E. coli swine19, swine22, swine54, and swine67 also belong to ETEC/STEC and display the same sequence type ST4214. The E. coli swine19 and swine22 display the same serotype O130:H45. The E. coli swine54 and swine67 display the same serotype O3:H45, similar to our collected the E. coli CAU15104, CAU15134, and CAU16060. Five ETEC/STEC isolates recovered from pigs with enteric colibacillosis in Spain display the serotype O141:H4 and sequence type ST10 (). In the present study, all of the ST4214 ETEC/STEC we collected were MDR (at least three different classes of antimicrobials) and showed MDR to PB, TE, and NAL, carried 17–19 antimicrobial-resistant genes and 8–11 virulence genes. Besides, all the ST4214 ETEC/STEC harbored aminoglycoside-resistant genes (aadA2 and aph(3)-Ia), phenicol-resistant genes (cmlA1 and floR), tetracycline-resistant genes [tet(A) and tet(M)], trimethoprim-resistant gene (dfrA12), sulfonamide-resistant genes (sul1, sul2, and sul3), streptomycin-resistant genes (strA and strB), and colistin-resistant genes (mcr-1.1). The ST4214 ETEC/STEC also harbored fimbrial adhesin genes (fedA and fedF), adherence gene (iha), heat-labile enterotoxin (LT) gene (ltcA), heat-stabile enterotoxin (ST) gene (stb), Shigella extracellular protein gene (sepA), and Shiga toxin 2 variant e genes (stx2A and stx2B). We observed the ST4214 strains were recovered from different provinces (Shandong, Jiangsu and Liaoning) and years (2012, 2014, 2015, and 2016) in China, which indicated this clone strains have spread in swine and should be brought to our attention.

In addition, the clinical isolates of the E. coli CAU16175 and CAU16177 belonged to aEPEC, displaying different serotype and sequence type, O4:H11 and O103:H2, ST29 and ST20, respectively. For aEPEC, serotypes O45 and O123 are frequently occurring in diarrheagenic pigs (, ). The E. coli CAU16175 and CAU16177 also showed MDR to AMC, KAN, PB, TE, NAL, and CHL and carried 19/23 antimicrobial-resistant genes and 17/11 virulence genes. They both harbored beta-lactamase-resistant genes (blaOXA−1), aminoglycoside-resistant genes (aac(3)-IVa, aac(6)Ib-cr, aph(3)-Ia and aph(4)-Ia), phenicol-resistant genes (cmlA1, catB3, and floR), tetracycline-resistant genes [tet(A)], trimethoprim-resistant gene (dfrA12), sulfonamide-resistant genes (sul1, sul2, and sul3), rifampicin-resistant gene (ARR-3), and colistin-resistant genes (mcr-1.1). Interestingly, E. coli CAU16177 also harbored mcr-3.1. Four mcr-1– and mcr-3-positive E. coli have been reported, and three E. coli isolates were recovered from pigs (). The E. coli CAU16175 and CAU16177 both harbored type III secretion system-associated virulence genes (cif, espA, espB, and espJ), non–LEE-encoded effector gene (nleB), glutamate decarboxylase gene (gad), increased serum survival gene (iss), a marker gene for EPEC, intimin gene (eae), and translocated intimin receptor gene (tir).

The E. coli CAU16175 carries IS26-enriched MDR region in pCAU16175_1 (IncHI2 type). The IncHI2-type plasmids have been discovered as genetic elements mediating the transmission of MDR genes (). IS26-flanked Tns play an increasingly critical role in the mobilization and development of antimicrobial-resistant genes (). So far, there are 51 Tns related with IS26 from the Tn registry website. In an individual E. coli strain heterogeneous resistance-encoding plasmid, polymorphic MDR regions driven by IS26-flanked Tns have been detected (). From the BLAST analysis, we found that there were abundant IS26-enriched MDR regions in Salmonella and E. coli, which were mostly isolated from humans and animals. The results showed that the plasmid carrying IS26-enriched MDR region has been widely distributed in humans and consumption animals (Supplementary Table 1). Combined with the antimicrobial susceptibility testing, we can deduce that the E. coli CAU16175 isolate has MDR and is difficult to control.

The E. coli CAU16175 isolate also carries the mcr-1.1 gene in pCAU16175_3 (IncFII type). The emergence of the mcr-1 gene can be traced back to the E. coli isolated in the 1980s, and the outbreak of chicken-derived mcr-1–containing E. coli started in 2009 ().The mcr-1 gene has been characterized in various genetic backgrounds and observed on a variety of plasmid type, including Incl2, IncX4, IncHI2, IncP, IncHI1, IncFII, IncFI, IncFIB, F18:A-:B+, IncY, IncK, and phage-like plasmid (). Most of the recently reported the mcr-1 genes were primarily mobilized by an ISApl1 composite Tns Tn6330 and Tn6390 (, ). The ISApl1 would be lost over time, leading to the stability of the mcr-1 gene on plasmids (, ). Thus, only the truncated ISApl1 will lose the ability to transfer the mcr-1 gene.

Furthermore, the mcr-1.1 gene is located within the Tn2 derivative in pCAU16175-3. From the Tn registry website (https://transposon.lstmed.ac.uk/), we noticed the mcr-5 gene and the mcr-3.6 gene could be mobilized by Tn6452 and Tn6518 (belonged to Tn2 family). For the Tn6452, the mcr-5 gene was embedded within a Tn3-family Tn with 38-bp inverted repeats and flanked by 5-bp DRs, which were usually generated during the insertion (, ). Although DRs appear at the flanking site of the Tn2 derivative, the whole structure did not move by transposition because of truncated tnpA and deleted tnpR, which are essential to occur transposition for Tn2.

Conclusions

The current work shows the genetic characteristics of five DEC strains that exhibited MDR, including colistin resistance. Our data indicate that the ST4214 ETEC/STEC carried MDR and multivirulence genes and that the E. coli CAU16175 contains IS26-enriched MDR region and the mcr-1.1 gene, which is located within a Tn2 derivative. The coexistence of MDR and multivirulence in DEC may seriously compromise the effectiveness of clinical therapy, and heightened efforts are needed to control their dissemination.

Statements

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/, SRR10813965; https://www.ncbi.nlm.nih.gov/, SRR10828049; https://www.ncbi.nlm.nih.gov/, SRR10828048; https://www.ncbi.nlm.nih.gov/, SRR10828047; and https://www.ncbi.nlm.nih.gov/, SRR10828046.

Ethics statement

The animal study was reviewed and approved by the Animal Ethics Committee of the China Agricultural University under the protocol CAU20140616-1.

Author contributions

LG and YZ conceived and designed the experiments. LG, JW, SW, JS, and XW performed the experiments. LG analyzed the sequencing data and wrote the manuscript. YZ revised the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Key R&D Program of China (Project No. 2017YFD0502200) and the National Natural Science Foundation of China (Project Nos. 31873034 and 31672613).

Acknowledgments

We would like to thank Prof. Wang Yang (China Agricultural University) for providing the E. coli J53 strain.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fvets.2020.00503/full#supplementary-material

    Abbreviations

  • DEC

    diarrheagenic Escherichia coli

  • WGS

    whole-genome sequencing

  • MDR

    multidrug resistance

  • ETEC

    enterotoxigenic E. coli

  • STEC

    Shiga-toxigenic E. coli

  • aEPEC

    atypical enteropathogenic E. coli

  • tEPEC

    typical enteropathogenic E. coli

  • PWD

    postweaning diarrhea

  • IS

    insertion sequence

  • Tn

    transposon

  • PCR

    polymerase chain reaction

  • DR

    direct repeat.

References

Summary

Keywords

Escherichia coli, whole-genome sequencing, multidrug resistance, mcr-1, Tn2, swine

Citation

Guo L, Wang J, Wang S, Su J, Wang X and Zhu Y (2020) Genome Characterization of mcr-1–Positive Escherichia coli Isolated From Pigs With Postweaning Diarrhea in China. Front. Vet. Sci. 7:503. doi: 10.3389/fvets.2020.00503

Received

01 April 2020

Accepted

02 July 2020

Published

25 August 2020

Volume

7 - 2020

Edited by

Rafael Vignoli, University of the Republic, Uruguay

Reviewed by

José Alejandro Di Conza, University of Buenos Aires, Argentina; Nilton Lincopan, University of São Paulo, Brazil

Updates

Copyright

*Correspondence: Yaohong Zhu

This article was submitted to Veterinary Epidemiology and Economics, a section of the journal Frontiers in Veterinary Science

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics